Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Liabilities (2018 - 2025)

Dna X filings provide 8 years of Total Liabilities readings, the most recent being $50.6 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 11.41% to $50.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.6 million, a 11.41% increase, with the full-year FY2025 number at $50.6 million, up 11.41% from a year prior.
  • Total Liabilities hit $50.6 million in Q4 2025 for Dna X, up from $40.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $50.6 million in Q4 2025 to a low of $21.3 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $31.6 million (2023), compared with a mean of $32.2 million.
  • Biggest five-year swings in Total Liabilities: fell 28.99% in 2021 and later skyrocketed 64.27% in 2025.
  • Dna X's Total Liabilities stood at $22.5 million in 2021, then skyrocketed by 49.78% to $33.6 million in 2022, then rose by 0.1% to $33.7 million in 2023, then skyrocketed by 34.93% to $45.4 million in 2024, then rose by 11.41% to $50.6 million in 2025.
  • The last three reported values for Total Liabilities were $50.6 million (Q4 2025), $40.9 million (Q3 2025), and $37.4 million (Q2 2025) per Business Quant data.